Rizatriptan
CAS: 144034-80-0
Rif. 3D-UFA03480
| 1g | Fuori produzione | ||
| 5g | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione | ||
| 100mg | Fuori produzione | ||
| 250mg | Fuori produzione | ||
| 500mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Rizatriptan
Sinonimi:
- 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- 2-(5-((1H-1,2,4-Triazol-1-yl)methyl)-1H-indol-3-yl)-N,N-dimethylethanamine
- 3-[2-(Dimethylamino)ethyl]-5-(1H-1,2,4-triazol-1-ylmethyl)indole
- MK 462 free base
- N,N-Dimethyl-2-[5-(1,2,4-Triazol-1-Ylmethyl)-1H-Indol-3-Yl]Ethanamine
- N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine
- N,N-Dimethyl-5-(1H-1,2,4-Triazol-1-Ylmethyl)-1H-Indole-3-Ethanamine
- N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine benzoate (1:1)
- Risatriptan
Descrizione:
Rizatriptan belongs to the class of triptans and is used as a treatment for migraine. Rizatriptan binds to 5-HT2 receptors in the pain pathways of the brain and blocks the release of neurotransmitters such as serotonin, noradrenaline, and dopamine that are responsible for pain and other symptoms associated with migraine. This drug has been shown to be effective in clinical trials involving patients with chronic migraine (15 or more headache days per month). It also has been shown to have few adverse effects, such as nausea, dizziness, and dry mouth.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
269.34 g/mol
Formula:
C15H19N5
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
